Dudediligence.

Apimeds Pharmaceuticals US, Inc

APUSAMEX · Pharmaceutical Preparations
Write an idea

Price
FilingsNewest: 8-K, Director or officer changeOct 1 →InsidersNo open-market buys or sales.→Financing →PeersClosest companies: SXTP, CELZ, FTH→

From the filings

Figures

Net income
−$58.2Mlast 12 months
Operating cash flow
−$11.0Mlast 12 months
Cash and equivalents
$278,371at the last balance sheet
Shares outstanding
1.5M shareson issue
Every year and quarter →